Quercetin and Its Nano-Formulations for Brain Tumor Therapy—Current Developments and Future Perspectives for Paediatric Studies
暂无分享,去创建一个
[1] Kaijian Hou,et al. Antioxidants in brain tumors: current therapeutic significance and future prospects , 2022, Molecular Cancer.
[2] A. Rahmani,et al. Potential Therapeutic Targets of Resveratrol, a Plant Polyphenol, and Its Role in the Therapy of Various Types of Cancer , 2022, Molecules.
[3] K. Grabowska,et al. A Flavonoid on the Brain: Quercetin as a Potential Therapeutic Agent in Central Nervous System Disorders , 2022, Life.
[4] M. Aschner,et al. Quercetin and Glioma: Which signaling pathways are involved? , 2022, Current molecular pharmacology.
[5] Muhammad Hanif,et al. An insight into anticancer, antioxidant, antimicrobial, antidiabetic and anti-inflammatory effects of quercetin: a review , 2022, Polymer Bulletin.
[6] M. Naumowicz,et al. A Preliminary Study of the Effect of Quercetin on Cytotoxicity, Apoptosis, and Stress Responses in Glioblastoma Cell Lines , 2022, International journal of molecular sciences.
[7] A. Chen,et al. Targeted disruption of tumor vasculature via polyphenol nanoparticles to improve brain cancer treatment , 2021, Cell reports. Physical science.
[8] A. Azzariti,et al. Microfluidic-Assisted Preparation of Targeted pH-Responsive Polymeric Micelles Improves Gemcitabine Effectiveness in PDAC: In Vitro Insights , 2021, Cancers.
[9] J. Barnholtz-Sloan,et al. Epidemiology of Brain and Other CNS Tumors , 2021, Current Neurology and Neuroscience Reports.
[10] K. Kerl,et al. The Growing Relevance of Immunoregulation in Pediatric Brain Tumors , 2021, Cancers.
[11] H. Mahajan,et al. Nanoemulsion containing a synergistic combination of curcumin and quercetin for nose-to-brain delivery: In vitro and in vivo studies , 2021, Asian Pacific Journal of Tropical Biomedicine.
[12] Min Suk Shim,et al. Polysorbate-Based Drug Formulations for Brain-Targeted Drug Delivery and Anticancer Therapy , 2021, Applied Sciences.
[13] H. Santos,et al. Microfluidic preparation and in vitro evaluation of iRGD-functionalized solid lipid nanoparticles for targeted delivery of paclitaxel to tumor cells. , 2021, International journal of pharmaceutics.
[14] E. C. D. de Lange,et al. Understanding Drug Delivery to the Brain Using Liposome-Based Strategies: Studies that Provide Mechanistic Insights Are Essential , 2021, The AAPS Journal.
[15] P. Shende,et al. Quercetin‐loaded platelets as a potential targeted therapy for glioblastoma multiforme cell line U373‐MG , 2021, Biotechnology journal.
[16] N. Denora,et al. The complexity of the blood-brain barrier and the concept of age-related brain targeting: challenges and potential of novel solid lipid-based formulations. , 2021, Journal of pharmaceutical sciences.
[17] R. Rahbarghazi,et al. Exosomal delivery of therapeutic modulators through the blood–brain barrier; promise and pitfalls , 2021, Cell & bioscience.
[18] Haowen Li,et al. Enhancement of oral bioavailability of quercetin by metabolic inhibitory nanosuspensions compared to conventional nanosuspensions , 2021, Drug delivery.
[19] J. Sharifi‐Rad,et al. Neuropharmacological Effects of Quercetin: A Literature-Based Review , 2021, Frontiers in Pharmacology.
[20] Priyanka Singh,et al. The role of quercetin in plants. , 2021, Plant physiology and biochemistry : PPB.
[21] A. Iyer,et al. Recent advances in nano delivery systems for blood-brain barrier (BBB) penetration and targeting of brain tumors. , 2021, Drug discovery today.
[22] M. Moniruzzaman,et al. Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook , 2021, Pharmaceutics.
[23] R. Bauer,et al. Natural products in drug discovery: advances and opportunities , 2021, Nature Reviews Drug Discovery.
[24] H. Santos,et al. Preparation of Cetyl Palmitate-based PEGylated Solid Lipid Nanoparticles by Microfluidic technique. , 2020, Acta biomaterialia.
[25] J. Trevino,et al. Non-Invasive Strategies for Nose-to-Brain Drug Delivery , 2020, Journal of clinical trials.
[26] Guo-Dong Lu,et al. Quercetin Induces Apoptosis via Downregulation of Vascular Endothelial Growth Factor/Akt Signaling Pathway in Acute Myeloid Leukemia Cells , 2020, Frontiers in Pharmacology.
[27] L. Alvarez-Arellano,et al. Neuroprotective Effects of Quercetin in Pediatric Neurological Diseases , 2020, Molecules.
[28] N. Colabufo,et al. Induced expression of P-gp and BCRP transporters on brain endothelial cells using transferrin functionalized nanostructured lipid carriers: A first step of a potential strategy for the treatment of Alzheimer's disease. , 2020, International journal of pharmaceutics.
[29] Chuntai Liu,et al. Quercetin-loaded selenium nanoparticles inhibit amyloid-β aggregation and exhibit antioxidant activity , 2020 .
[30] S. Reis,et al. RVG29-Functionalized Lipid Nanoparticles for Quercetin Brain Delivery and Alzheimer’s Disease , 2020, Pharmaceutical Research.
[31] Dong Min Lee,et al. Quercetin and chloroquine synergistically kill glioma cells by inducing organelle stress and disrupting Ca2+ homeostasis. , 2020, Biochemical pharmacology.
[32] Marc Schneider,et al. Key for crossing the BBB with nanoparticles: the rational design , 2020, Beilstein journal of nanotechnology.
[33] Qi Li,et al. Exosomes as Actively Targeted Nanocarriers for Cancer Therapy , 2020, International journal of nanomedicine.
[34] H. Friedman,et al. Management of glioblastoma: State of the art and future directions. , 2020, CA: a cancer journal for clinicians.
[35] B. Salehi,et al. Therapeutic Potential of Quercetin: New Insights and Perspectives for Human Health , 2020, ACS omega.
[36] E. Fanizza,et al. PEGylated Solid Lipid Nanoparticles for Brain Delivery of Lipophilic Kiteplatin Pt(IV) Prodrugs: an In Vitro Study. , 2020, International journal of pharmaceutics.
[37] M. Ersoz,et al. Quercetin-loaded nanoparticles enhance cytotoxicity and antioxidant activity on C6 glioma cells , 2020, Pharmaceutical development and technology.
[38] S. Reis,et al. Quercetin lipid nanoparticles functionalized with transferrin for Alzheimer's disease. , 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[39] S. Dharmaraj,et al. Selenium and selenoproteins: it’s role in regulation of inflammation , 2020, Inflammopharmacology.
[40] Liang Zhao,et al. Brain delivery of quercetin-loaded exosomes improved cognitive function in AD mice by inhibiting phosphorylated tau-mediated neurofibrillary tangles , 2020, Drug delivery.
[41] A. Hosseini,et al. Quercetin: A promising phytochemical for the treatment of glioblastoma multiforme , 2019, BioFactors.
[42] S. Maleki,et al. Anti-inflammatory effects of flavonoids. , 2019, Food chemistry.
[43] Camila Felix de Lima Fernandes,et al. Heat Shock Proteins in Glioblastoma Biology: Where Do We Stand? , 2019, International journal of molecular sciences.
[44] Arun Prasath,et al. Nanoparticles' interactions with vasculature in diseases. , 2019, Chemical Society reviews.
[45] M. Marra,et al. Dietary Quercetin and Kaempferol: Bioavailability and Potential Cardiovascular-Related Bioactivity in Humans , 2019, Nutrients.
[46] A. Esmaeili,et al. Quercetin conjugated with superparamagnetic iron oxide nanoparticles improves learning and memory better than free quercetin via interacting with proteins involved in LTP , 2019, Scientific Reports.
[47] A. Esmaeili,et al. Quercetin conjugated with superparamagnetic iron oxide nanoparticles improves learning and memory better than free quercetin via interacting with proteins involved in LTP , 2019, Scientific Reports.
[48] Matthew A. Taylor,et al. Quercetin and Sodium Butyrate Synergistically Increase Apoptosis in Rat C6 and Human T98G Glioblastoma Cells Through Inhibition of Autophagy , 2019, Neurochemical Research.
[49] Matthew A. Taylor,et al. Quercetin and Sodium Butyrate Synergistically Increase Apoptosis in Rat C6 and Human T98G Glioblastoma Cells Through Inhibition of Autophagy , 2019, Neurochemical Research.
[50] T. Webster,et al. Preparation, intestinal segment stability, and mucoadhesion properties of novel thymopentin-loaded chitosan derivatives coated with poly (n-butyl) cyanoacrylate nanoparticles , 2019, International Journal of Nanomedicine.
[51] Giles W. Robinson,et al. Challenges to curing primary brain tumours , 2019, Nature Reviews Clinical Oncology.
[52] A. Esmaeili,et al. Using superparamagnetic iron oxide nanoparticles to enhance bioavailability of quercetin in the intact rat brain , 2018, BMC Pharmacology and Toxicology.
[53] S. Wolffram,et al. Bioavailability of Quercetin from Onion Extracts after Intraruminal Application in Cows. , 2018, Journal of agricultural and food chemistry.
[54] G. Currie. Pharmacology, Part 2: Introduction to Pharmacokinetics , 2018, The Journal of Nuclear Medicine Technology.
[55] Mohammadreza Mirzababaei,et al. Quercetin in Food: Possible Mechanisms of Its Effect on Memory. , 2018, Journal of food science.
[56] R. Packer,et al. Pediatric Brain Tumors. , 2018, Neurologic clinics.
[57] G. Williamson,et al. The Bioavailability, Transport, and Bioactivity of Dietary Flavonoids: A Review from a Historical Perspective. , 2018, Comprehensive reviews in food science and food safety.
[58] D. Giakoumettis,et al. C6 cell line: the gold standard in glioma research. , 2018, Hippokratia.
[59] C. Duma,et al. Proof of Concept in a Case Study of Glioblastoma Multiforme Successfully Treated with IV Quercetin in Combination with Leading Edge Gamma Knife and Standard Treatments , 2018 .
[60] W. Muangsiri,et al. Solubilization of fluocinolone acetonide by cosolvents and surfactants for buccal solution preparation , 2018 .
[61] E. Neromyliotis,et al. Paediatric gliomas: diagnosis, molecular biology and management. , 2018, Annals of translational medicine.
[62] G. Borge,et al. Bioavailability of Quercetin in Humans with a Focus on Interindividual Variation. , 2018, Comprehensive reviews in food science and food safety.
[63] A. Martelli,et al. Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging , 2018, Oncotarget.
[64] V. Shah,et al. Brain Cancer: Implication to Disease, Therapeutic Strategies and Tumor Targeted Drug Delivery Approaches. , 2018, Recent patents on anti-cancer drug discovery.
[65] Michael D. Taylor,et al. Review of molecular classification and treatment implications of pediatric brain tumors , 2017, Current opinion in pediatrics.
[66] H. Mahajan,et al. Quercetin Loaded Nanostructured Lipid Carriers for Nose to Brain Delivery: In Vitro and In Vivo Studies , 2018 .
[67] A. Lampen,et al. Safety Aspects of the Use of Quercetin as a Dietary Supplement , 2018, Molecular nutrition & food research.
[68] A. Bishayee,et al. The Role of Resveratrol in Cancer Therapy , 2017, International journal of molecular sciences.
[69] D. Kalman,et al. Curcumin: A Review of Its’ Effects on Human Health , 2017, Foods.
[70] C. Bhattacharjee,et al. Nanotechnology and nanocarrier-based approaches on treatment of degenerative diseases , 2017, International Nano Letters.
[71] Zoraida P. Aguilar,et al. Intravenous Administration of Functionalized Magnetic Iron Oxide Nanoparticles Does Not Induce CNS Injury in the Rat: Influence of Spinal Cord Trauma and Cerebrolysin Treatment. , 2017, International review of neurobiology.
[72] R. Kumar,et al. Promises of a biocompatible nanocarrier in improved brain delivery of quercetin: Biochemical, pharmacokinetic and biodistribution evidences. , 2016, International journal of pharmaceutics.
[73] Liang Wang,et al. Quercetin nanoparticles induced autophagy and apoptosis through AKT/ERK/Caspase-3 signaling pathway in human neuroglioma cells: In vitro and in vivo. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[74] Müzeyyen Berkel Kaşıkcı,et al. Bioavailability of Quercetin , 2016 .
[75] R. Ruhela,et al. Nanomedicine in Central Nervous System (CNS) Disorders: A Present and Future Prospective. , 2016, Advanced pharmaceutical bulletin.
[76] G. Wang,et al. Quercetin-loaded freeze-dried nanomicelles: Improving absorption and anti-glioma efficiency in vitro and in vivo. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[77] Subramani Parasuraman,et al. Overviews of Biological Importance of Quercetin: A Bioactive Flavonoid , 2016, Pharmacognosy reviews.
[78] L. Alpsoy,et al. Superparamagnetic iron oxide conjugated with folic acid and carboxylated quercetin for chemotherapy applications , 2016 .
[79] Yinping Huang,et al. Superparamagnetic Iron Oxide Nanoparticles Modified with Tween 80 Pass through the Intact Blood-Brain Barrier in Rats under Magnetic Field. , 2016, ACS applied materials & interfaces.
[80] D. Trisciuoglio,et al. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies , 2016, Aging.
[81] Jun Hu,et al. Pharmacokinetics and antitumor efficacy of DSPE-PEG2000 polymeric liposomes loaded with quercetin and temozolomide: Analysis of their effectiveness in enhancing the chemosensitization of drug-resistant glioma cells , 2016, International journal of molecular medicine.
[82] G. Heeba,et al. Dual effects of quercetin in doxorubicin‐induced nephrotoxicity in rats and its modulation of the cytotoxic activity of doxorubicin on human carcinoma cells , 2014, Environmental toxicology.
[83] Voichita D. Marinescu,et al. The Human Glioblastoma Cell Culture Resource: Validated Cell Models Representing All Molecular Subtypes , 2015, EBioMedicine.
[84] Z. Khan,et al. Poly(n-butylcyanoacrylate) nanoparticles for oral delivery of quercetin: preparation, characterization, and pharmacokinetics and biodistribution studies in Wistar rats , 2015, International journal of nanomedicine.
[85] M. Khaniani,et al. Molecular mechanisms of apoptosis and roles in cancer development and treatment. , 2015, Asian Pacific journal of cancer prevention : APJCP.
[86] F. Lombó,et al. Bioavailability of Dietary Polyphenols and Gut Microbiota Metabolism: Antimicrobial Properties , 2015, BioMed research international.
[87] M. Barbaccia,et al. Placebo-controlled trials in pediatrics and the child’s best interest , 2015, Italian Journal of Pediatrics.
[88] Yukun Cui,et al. Quercetin promotes cell apoptosis and inhibits the expression of MMP-9 and fibronectin via the AKT and ERK signalling pathways in human glioma cells , 2015, Neurochemistry International.
[89] A. Carcaboso,et al. Nanomedicines in the future of pediatric therapy. , 2014, Advanced drug delivery reviews.
[90] Q. Lan,et al. Quercetin sensitizes human glioblastoma cells to temozolomide in vitro via inhibition of Hsp27 , 2014, Acta Pharmacologica Sinica.
[91] H. Mahajan,et al. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting , 2014, Drug delivery.
[92] A. Pandey,et al. Chemistry and Biological Activities of Flavonoids: An Overview , 2013, TheScientificWorldJournal.
[93] K. Ahn,et al. Quercetin Induces Mitochondrial Mediated Apoptosis and Protective Autophagy in Human Glioblastoma U373MG Cells , 2013, Oxidative medicine and cellular longevity.
[94] Gang Wang,et al. PEG2000-DPSE-coated quercetin nanoparticles remarkably enhanced anticancer effects through induced programed cell death on C6 glioma cells. , 2013, Journal of biomedical materials research. Part A.
[95] W. Rzeski,et al. Apoptosis induction in human glioblastoma multiforme T98G cells upon temozolomide and quercetin treatment , 2013, Tumor Biology.
[96] Say Chye Joachim Loo,et al. Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE–cadherin , 2013, Nature Communications.
[97] J. Minturn,et al. Gliomas in Children , 2013, Current Treatment Options in Neurology.
[98] D. Mcclements,et al. Encapsulation and release of hydrophobic bioactive components in nanoemulsion-based delivery systems: impact of physical form on quercetin bioaccessibility. , 2013, Food & function.
[99] M. Valadares,et al. Bioconversion of quercetin and rutin and the cytotoxicity activities of the transformed products. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[100] Muhammad Rashid Khan,et al. Antioxidant activity, total phenolic and total flavonoid contents of whole plant extracts Torilis leptophylla L , 2012, BMC Complementary and Alternative Medicine.
[101] J. Vacek,et al. Quercetin, Quercetin Glycosides and Taxifolin Differ in their Ability to Induce AhR Activation and CYP1A1 Expression in HepG2 Cells , 2012, Phytotherapy research : PTR.
[102] P. van Bladeren,et al. A state-of-the-art overview of the effect of metabolic conjugation on the biological activity of flavonoids. , 2012, Food & function.
[103] N. Wilson,et al. Heat shock protein 27 (HSP27): biomarker of disease and therapeutic target , 2012, Fibrogenesis & tissue repair.
[104] Gang Wang,et al. Effects of quercetin nanoliposomes on C6 glioma cells through induction of type III programmed cell death , 2012, International journal of nanomedicine.
[105] N. Wilson,et al. Heat shock protein 27 ( HSP 27 ) : biomarker of disease and therapeutic target , 2012 .
[106] J. Terao,et al. Accumulation of orally administered quercetin in brain tissue and its antioxidative effects in rats. , 2011, Free radical biology & medicine.
[107] D. Min,et al. Quercetin-induced downregulation of phospholipase D1 inhibits proliferation and invasion in U87 glioma cells. , 2011, Biochemical and biophysical research communications.
[108] H. Berg,et al. The EU paediatric regulation: Effects on paediatric psychopharmacology in Europe , 2011, European Neuropsychopharmacology.
[109] H. Galla,et al. Transport of Poly(n-butylcyano-acrylate) nanoparticles across the blood-brain barrier in vitro and their influence on barrier integrity. , 2011, Biochemical and biophysical research communications.
[110] Rishi Kapil,et al. Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery , 2011, The Journal of pharmacy and pharmacology.
[111] M. Lafon. Rabies virus receptors , 2005, Journal of NeuroVirology.
[112] M. Mahmoudi,et al. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. , 2011, Advanced drug delivery reviews.
[113] W. Rzeski,et al. Temozolomide, quercetin and cell death in the MOGGCCM astrocytoma cell line. , 2010, Chemico-biological interactions.
[114] H. Bhat,et al. Dietary quercetin exacerbates the development of estrogen-induced breast tumors in female ACI rats. , 2010, Toxicology and applied pharmacology.
[115] C. Peng,et al. Quercetin and ferulic acid aggravate renal carcinoma in long-term diabetic victims. , 2010, Journal of agricultural and food chemistry.
[116] P. Kearns,et al. The role of the 'innovative therapies for children with cancer' (ITCC) European consortium. , 2010, Cancer treatment reviews.
[117] E. McCabe. Nanopediatrics: Enabling Personalized Medicine for Children , 2010, Pediatric Research.
[118] L. Bredsdorff,et al. Relative bioavailability of the flavonoids quercetin, hesperetin and naringenin given simultaneously through diet , 2010, European Journal of Clinical Nutrition.
[119] Michele Zoli,et al. Structural and functional diversity of native brain neuronal nicotinic receptors. , 2009, Biochemical pharmacology.
[120] Giuseppe Trapani,et al. New strategies to deliver anticancer drugs to brain tumors , 2009, Expert opinion on drug delivery.
[121] Chen Jiang,et al. Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles. , 2009, Biomaterials.
[122] E. Filippi-Chiela,et al. Resveratrol and quercetin cooperate to induce senescence‐like growth arrest in C6 rat glioma cells , 2009, Cancer science.
[123] L. Moreno,et al. Glucuronidated and sulfated metabolites of the flavonoid quercetin prevent endothelial dysfunction but lack direct vasorelaxant effects in rat aorta. , 2009, Atherosclerosis.
[124] J. Bruss,et al. The economics of pediatric formulation development for off-patent drugs. , 2008, Clinical therapeutics.
[125] Xing Tang,et al. Pharmacokinetic interaction between tanshinones and polyphenolic extracts of salvia miltinorrhiza BUNGE after intravenous administration in rats. , 2008, Biological & pharmaceutical bulletin.
[126] F. Perez-Vizcaino,et al. Glucuronidated metabolites of the flavonoid quercetin do not auto-oxidise, do not generate free radicals and do not decrease nitric oxide bioavailability. , 2008, Planta medica.
[127] A. Bast,et al. Health effects of quercetin: from antioxidant to nutraceutical. , 2008, European journal of pharmacology.
[128] Saengrawee Sutthiparinyanont,et al. Anxiety and cognitive effects of quercetin liposomes in rats. , 2008, Nanomedicine : nanotechnology, biology, and medicine.
[129] S. Kang,et al. Underlying Mechanism of Quercetin-induced Cell Death in Human Glioma Cells , 2008, Neurochemical Research.
[130] D. Rai,et al. Quercetin: A Versatile Flavonoid , 2007 .
[131] G. Bartosz,et al. Antioxidative and prooxidative effects of quercetin on A549 cells , 2007, Cell biology international.
[132] A. Bernardi,et al. Ecto-5'-nucleotidase/CD73 inhibition by quercetin in the human U138MG glioma cell line. , 2007, Biochimica et biophysica acta.
[133] G. Hard,et al. Re-evaluation of the kidney tumors and renal histopathology occurring in a 2-year rat carcinogenicity bioassay of quercetin. , 2007, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[134] G. Ponchel,et al. Design aspects of poly(alkylcyanoacrylate) nanoparticles for drug delivery , 2007, Journal of drug targeting.
[135] E. Braganhol,et al. Antiproliferative effect of quercetin in the human U138MG glioma cell line , 2006, Anti-cancer drugs.
[136] K. Kisich,et al. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. , 2005, American journal of respiratory and critical care medicine.
[137] T. Ryken,et al. Genetic characterization of commonly used glioma cell lines in the rat animal model system. , 2005, Neurosurgical focus.
[138] M. Lean,et al. DISPOSITION AND METABOLISM OF [2-14C]QUERCETIN-4′-GLUCOSIDE IN RATS , 2005, Drug Metabolism and Disposition.
[139] R. Egleton,et al. Modulation of cerebral microvascular permeability by endothelial nicotinic acetylcholine receptors. , 2005, American journal of physiology. Heart and circulatory physiology.
[140] Z. Zuo,et al. Pharmacokinetics and Modeling of Quercetin and Metabolites , 2005, Pharmaceutical Research.
[141] G. Grant,et al. Absorption of Quercetin and Rutin in Rat Small Intestine , 2005, Annals of Nutrition and Metabolism.
[142] D. Barron,et al. In vitro biological properties of flavonoid conjugates found in vivo , 2005, Free radical research.
[143] Gary Williamson,et al. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. , 2005, The American journal of clinical nutrition.
[144] L. Mira,et al. Plasma quercetin metabolites: structure-antioxidant activity relationships. , 2004, Archives of biochemistry and biophysics.
[145] P. Toutain,et al. Bioavailability and its assessment. , 2004, Journal of veterinary pharmacology and therapeutics.
[146] P. Hollman. Absorption, Bioavailability, and Metabolism of Flavonoids , 2004 .
[147] G. Williamson,et al. Metabolism of quercetin-7- and quercetin-3-glucuronides by an in vitro hepatic model: the role of human beta-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism. , 2003, Biochemical pharmacology.
[148] Y. El‐Sayed,et al. Disposition of the Flavonoid Quercetin in Rats After Single Intravenous and Oral Doses , 2003, Drug development and industrial pharmacy.
[149] J. Changeux,et al. The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences. , 2002, Journal of neurobiology.
[150] C. Manach,et al. Quercetin, but not its glycosides, is absorbed from the rat stomach. , 2002, Journal of agricultural and food chemistry.
[151] N. Behan,et al. Poly n-butyl cyanoacrylate nanoparticles: a mechanistic study of polymerisation and particle formation. , 2001, Biomaterials.
[152] G. Jacobasch,et al. Pharmacokinetics and Bioavailability of Quercetin Glycosides in Humans , 2001, Journal of clinical pharmacology.
[153] H. Engelhard,et al. Therapeutic Effects of Sodium Butyrate on Glioma Cells in Vitro and in the Rat C6 Glioma Model , 2001, Neurosurgery.
[154] R. Walgren,et al. Cellular uptake of dietary flavonoid quercetin 4'-beta-glucoside by sodium-dependent glucose transporter SGLT1. , 2000, The Journal of pharmacology and experimental therapeutics.
[155] J. Terao,et al. Absorption and Metabolism of Quercetin in Caco-2 Cells , 1999 .
[156] O. Texier,et al. Bioavailability, metabolism and physiological impact of 4-oxo-flavonoids , 1996 .
[157] R. Ogilvie,et al. An introduction to pharmacokinetics. , 1983, Journal of chronic diseases.